Real-time enrollment status for this narcolepsy type 1 clinical trial
Current Status
Recruiting
Checked: October 15, 2026 at 10:32 AM UTC
| NCT Number | NCT07633301 |
| Recruiting Status | Recruiting |
| Condition | Narcolepsy Type 1 |
| Phase | PHASE2 |
| Target Enrollment | 92 participants |
| Active Locations | 3 sites in the US |
| Sponsor | Takeda |
| Last Updated on CT.gov | June 29, 2026 (Jun 29, 2026) |
As of October 15, 2026: Clinical trial NCT07633301 is currently recruiting participants. This phase2 study for narcolepsy type 1 is actively seeking new participants at 3 locations across the United States. The study is sponsored by Takeda. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07633301 is actively recruiting participants as of October 15, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 3 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07633301 was last updated Jun 29, 2026 (June 29, 2026). HelloStudys verifies this status automatically.